Paula G Heller Selected Research

Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)

1/2019	Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia.
10/2018	Autoantibodies in immune thrombocytopenia affect the physiological interaction between megakaryocytes and bone marrow extracellular matrix proteins.
1/2016	Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies.
6/2014	Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paula G Heller Research Topics

Disease

7	Essential Thrombocythemia 01/2020 - 02/2005
5	Hemorrhage 01/2021 - 08/2014
5	MYH9-Related Disorders 01/2016 - 03/2008
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019 - 06/2014
3	Inflammation (Inflammations) 01/2021 - 01/2019
3	Thrombocytopenia (Thrombopenia) 01/2019 - 06/2005
2	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 05/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 06/2005
2	Neoplasms (Cancer) 12/2016 - 06/2005
1	Disease Progression 01/2021
1	Splenomegaly 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Thrombophilia 01/2019
1	Thrombosis (Thrombus) 12/2016
1	Anemia 04/2016
1	Hearing Loss (Hearing Impairment) 01/2016
1	Sensorineural Hearing Loss 01/2016
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 09/2014
1	Hyperplasia 01/2009
1	Thrombocytosis (Thrombocythemia) 08/2005
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2005
1	Moyamoya Disease (Moya-Moya Disease) 08/2005

Drug/Important Bio-Agent (IBA)

3	Hemostatics (Antihemorrhagics)IBA 01/2020 - 01/2017
3	Inosine Triphosphate (ITP)IBA 01/2019 - 06/2014
3	anagrelide (Agrylin)FDA LinkGeneric 04/2016 - 02/2005
3	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2016 - 03/2008
3	Nonmuscle Myosin Type IIAIBA 01/2013 - 03/2008
2	AutoantibodiesIBA 01/2021 - 10/2018
2	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2017 - 01/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2021
1	LipopolysaccharidesIBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	LigandsIBA 01/2020
1	Collagen ReceptorsIBA 01/2019
1	CytokinesIBA 01/2019
1	Extracellular Matrix ProteinsIBA 10/2018
1	Nucleosomes (Nucleosome)IBA 12/2016
1	AntibodiesIBA 01/2016
1	Amino Acids FDA Link 01/2016
1	von Willebrand FactorIBA 09/2014
1	Interleukin-6 (Interleukin 6)IBA 10/2010
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2010
1	Cytokine Receptor gp130IBA 10/2010
1	Thrombopoietin (c-mpl Ligand)IBA 05/2010
1	Interleukin-8 (Interleukin 8)IBA 01/2009
1	ChemokinesIBA 01/2009
1	SmokeIBA 08/2005
1	Transcription Factors (Transcription Factor)IBA 06/2005
1	platelet-derived growth factor AIBA 02/2005
1	platelet-derived growth factor ABIBA 02/2005
1	Messenger RNA (mRNA)IBA 02/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2005

Therapy/Procedure

2	Therapeutics 01/2019 - 04/2016
1	Secondary Prevention 01/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2017
1	Hysterectomy 08/2014
1	Blood Transfusion (Blood Transfusions) 08/2014
1	Stents 08/2005